$3.07B in CY2024 Part D spend3.8M claims · 1.1M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Linaclotide used for?
LINZESS is indicated for the treatment of: • irritable bowel syndrome with constipation (IBS-C) in adults and pediatric patients 7 years of age and older • chronic idiopathic constipation (CIC) in ....
Is there a generic for Linaclotide?
No. Linaclotide is brand-only with no generic equivalents currently in market.
How much does my plan pay for Linaclotide?
Across 329 Part D plans, Linaclotide averages $9.03/unit (NADAC). Lowest available: $9.02/unit. Highest in distribution: $9.03/unit.
Is Linaclotide on the FDA shortage list?
No. Linaclotide is not currently on the FDA Drug Shortage Database.
8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (3 approvals on file) · NADAC unit costs: CMS NADAC weekly file (3 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.